News | October 03, 2011

Maquet Expands Cardiology Offerings With Acquisition of Atrium Medical


October 3, 2011 Maquet Cardiovascular has signed a definitive agreement to acquire Atrium Medical Corp. for $680 million. Atrium is a medical device technologies developer for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery and general surgery.  Atrium will operate as an independent, self-contained business unit of Maquet and will be led by current Atrium president Trevor Carlton.

The transaction is expected to close in the fourth quarter of 2011, subject to U.S. Federal Trade Commission (FTC) approval.

In the United States, Atrium is known for its ClearWay RX perfusion catheter, which delivers therapeutic agents via a balloon catheter, and is developing both coronary and peripheral stents. The company currently has a U.S. trial investigating the use of a balloon-expandable covered stent occlusive disease of the iliac artery.

Maquet offers devices for advanced surgical interventions, cardiovascular procedures and critical care. It develops and designs innovative products and therapeutic applications for the operating room, hybrid OR/cath lab, intensive care unit and patient transport. Cardiovascular specialties include intra-aortic balloon counterpulsation (IABC) therapy for cardiac assist; coronary artery bypass surgery; aortic and peripheral vascular surgery; and extracorporeal circulation. 

For more information: www.atriummed.com, www.maquet.com

 

 

Related Content

News | Intra-Aortic Balloon Pumps (IABP)

December 16, 2021 — Datascope/Getinge/Maquet has recalled the Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic ...

Home December 16, 2021
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 2, 2021 — Datascope/Getinge/Maquet is recalling its Cardiosave Hybrid/Rescue Intra-Aortic Balloon Pumps (IABP) ...

Home November 02, 2021
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all intra-aortic balloon ...

Home July 24, 2019
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 5, 2018 — The U.S. Food and Drug Administration (FDA) is evaluating recent reports of Getinge's Maquet ...

Home November 05, 2018
Home
News | Intra-Aortic Balloon Pumps (IABP)

September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of approximately ...

Home September 24, 2018
Home
News | Intra-Aortic Balloon Pumps (IABP)

June 6, 2018 — Maquet Datascope Corp. said it is recalling the CardioSave Hybrid Intra-aortic Balloon Pump (IABP) due to ...

Home June 06, 2018
Home
Feature | Intra-Aortic Balloon Pumps (IABP)

May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia ...

Home May 31, 2018
Home
Technology | Intra-Aortic Balloon Pumps (IABP)

May 2, 2017 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Teleflex Inc. AC3 Optimus ...

Home May 02, 2017
Home
News | Intra-Aortic Balloon Pumps (IABP) | Dave Fornell

January 3, 2017 — The Impella CP heart pump (Abiomed) demonstrated no improvement in mortality for patients with ...

Home January 03, 2017
Home
News | Intra-Aortic Balloon Pumps (IABP)

March 11, 2016 — Teleflex Inc. announced the worldwide recall of Arrow International intra-aortic balloon catheter kits ...

Home March 11, 2016
Home
Subscribe Now